We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
The FDA has picked apart the process of a Jubilant solid-dose plant in India and criticized it for repeating mistakes it had been told about in the past.